Jacobi Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,020
| Closed | -$374K | – | 450 |
|
|
2021
Q4 | $374K | Buy |
4,020
+500
| +14% | +$32.9K | 0.04% | 320 |
|
|
2021
Q3 | $210K | Hold |
3,520
| – | – | 0.03% | 389 |
|
|
2021
Q2 | $240K | Hold |
3,520
| – | – | 0.03% | 346 |
|
|
2021
Q1 | $244K | Hold |
3,520
| – | – | 0.04% | 322 |
|
|
2020
Q4 | $270K | Hold |
3,520
| – | – | 0.04% | 289 |
|
|
2020
Q3 | $263K | Hold |
3,520
| – | – | 0.05% | 267 |
|
|
2020
Q2 | $222K | Hold |
3,520
| – | – | 0.04% | 272 |
|
|
2020
Q1 | $148K | Hold |
3,520
| – | – | 0.03% | 289 |
|
|
2019
Q4 | $160K | Hold |
3,520
| – | – | 0.03% | 312 |
|
|
2019
Q3 | $161K | Hold |
3,520
| – | – | 0.03% | 293 |
|
|
2019
Q2 | $206K | Hold |
3,520
| – | – | 0.04% | 272 |
|
|
2019
Q1 | $158K | Buy |
3,520
+20
| +0.6% | +$917 | 0.04% | 260 |
|
|
2018
Q4 | $136K | Hold |
3,500
| – | – | 0.04% | 266 |
|
|
2018
Q3 | $161K | Hold |
3,500
| – | – | 0.04% | 259 |
|
|
2018
Q2 | $153K | Hold |
3,500
| – | – | 0.04% | 251 |
|
|
2018
Q1 | $124K | Hold |
3,500
| – | – | 0.04% | 264 |
|
|
2017
Q4 | $134K | Hold |
3,500
| – | – | 0.04% | 221 |
|
|
2017
Q3 | $92K | Hold |
3,500
| – | – | 0.03% | 254 |
|
|
2017
Q2 | $64K | Hold |
3,500
| – | – | 0.02% | 277 |
|
|
2017
Q1 | $49K | Buy |
3,500
+2,500
| +250% | +$37K | 0.03% | 243 |
|
|
2016
Q4 | $14K | Sell |
1,000
-2,500
| -71% | -$38.7K | 0.01% | 392 |
|
|
2016
Q3 | $64K | Hold |
3,500
| – | – | 0.03% | 205 |
|
|
2016
Q2 | $56K | Buy |
+3,500
| New | +$62.6K | 0.03% | 208 |
|
Jacobi Capital Management's ARNA Position: Q1 2022 in Review
Jacobi Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 4,020 shares — an estimated $374K sold.
Jacobi Capital Management first reported a position in ARNA in Q2 2016 and held it in 23 quarters. The position peaked at $374K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Jacobi Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Jacobi Capital Management sold 4,020 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $374K.
- Jacobi Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2016 and held it in 23 quarters.
- Jacobi Capital Management's Arena Pharmaceuticals Inc position peaked at $374K in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Jacobi Capital Management's 13F filing for Q1 2022, filed 6 May 2022.